Multiple law firms filed a class action lawsuit against Insulet Corporation. The suit alleges violations of federal securities laws. It claims Insulet made false and misleading statements regarding its manufacturing processes and controls.
The complaint states manufacturing issues created safety risks for customers. A Medical Device Correction in March 2026 impacted more Pod Products than initially disclosed.
The class period runs from February 21, 2025, to May 26, 2026. Investors must seek lead plaintiff status by August 31, 2026.